TY - JOUR
T1 - Updating the approaches to define susceptibility and resistance to anti-tuberculosis agents
T2 - implications for diagnosis and treatment
AU - Antimycobacterial Susceptibility Testing Group
AU - Machado, D
AU - Viveiros, M
PY - 2022/4/1
Y1 - 2022/4/1
N2 - Inappropriately high breakpoints have resulted in systematic false-susceptible AST results to anti-TB drugs. MIC, PK/PD and clinical outcome data should be combined when setting breakpoints to minimise the emergence and spread of antimicrobial resistance. https://bit.ly/3i43wb6
AB - Inappropriately high breakpoints have resulted in systematic false-susceptible AST results to anti-TB drugs. MIC, PK/PD and clinical outcome data should be combined when setting breakpoints to minimise the emergence and spread of antimicrobial resistance. https://bit.ly/3i43wb6
KW - Antimycobacterial Susceptibility Testing
KW - Breakpoints
KW - Antimicrobial resistance
UR - http://www.scopus.com/inward/record.url?scp=85128279327&partnerID=8YFLogxK
U2 - 10.1183/13993003.00166-2022
DO - 10.1183/13993003.00166-2022
M3 - Editorial
C2 - 35422426
AN - SCOPUS:85128279327
SN - 0903-1936
VL - 59
JO - The European respiratory journal
JF - The European respiratory journal
IS - 4
M1 - 2200166
ER -
